$CMPX
Compass Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Boston, MA
CMPX chart
What traders are saying about $CMPX
Latest postsCompass Therapeutics, Inc. news
- Wedbush maintains Compass Therapeutics at Neutral, lowers price target to $0.90 from $1
TradingView ·
- State Street reports 7.74M Compass Therapeutics (CMPX) shares, but voting power covers fewer.
Stock Titan ·
- Macro and Geopolitical Risks Threaten Compass Therapeutics’ Costs, Liquidity, and Clinical Operations
TipRanks ·
- Compass Therapeutics at Guggenheim conference: tovecimig faces FDA test By Investing.com
Investing.com Nigeria ·
- Compass Therapeutics, Inc. (CMPX) Misses Q3 EPS by 3c
StreetInsider ·
- Compass Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- Compass Therapeutics Reports 2026 Third Quarter Financial Results
TradingView ·
- Compass Therapeutics Q3 Results: Loss widens 87.5% YoY to $(0.15) per share
scanx.trade ·
- Compass Therapeutics Posts $27.2M Q3 Net Loss, $163M Cash Runway Into 2028
Minichart ·
- Compass Therapeutics 3Q 2026: EPS ($0.15) — 10-Q Summary
TradingView ·
- Compass Therapeutics Reports Q3 2026 Results, $27.2 Million Net Loss
TradingView ·
- Cash and securities total $163M as Compass Therapeutics (CMPX) posts a wider Q3 loss.
Stock Titan ·
Compass Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$66.5M | -$49.4M | -$42.5M | -$39.2M |
| Total assets (year end) | $219.6M | $140.4M | $156.9M | $199.6M |
| Cash and equivalents (year end) | $30.6M | $43.5M | $24.2M | $34.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Compass Therapeutics, Inc.
- Ticker
- CMPX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1738021
- Former names
- Olivia Ventures, Inc.
Frequently asked questions
What exchange is Compass Therapeutics, Inc. listed on?
Compass Therapeutics, Inc. trades on the Nasdaq under the ticker symbol CMPX.
What industry is Compass Therapeutics, Inc. in?
Compass Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Compass Therapeutics, Inc. headquartered?
Compass Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Compass Therapeutics, Inc.'s fiscal year end?
Compass Therapeutics, Inc.'s fiscal year ends on December 31.